OLIVIA BROWN: Open Payments
NPI 1598358285 · SALYERSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 27 payments from 10 companies in 2025. Trend: 2023 $260 · 2024 $377 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Axsome Therapeutics, Inc. | 3 | $36 |
| Gilead Sciences, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: MAVYRET, CAPLYTA, UBRELVY, SPRAVATO, Auvelity, VRAYLAR, Epclusa, VYNDAMAX.
Industry payments across KY — which companies pay providers there.
